P.O. Box 222-00623 Nairobi, Kenya
+254 707 040 440
Follow us

Noviguard 72% WP

  • Technical Name  Cymoxanil 80 g/kg + Mancozeb 640 g/kg
  • Recommended on Roses, Potato, Tomato and Onion.
  • Mode of Action

It is mixture of two fungicides - Mancozeb and Cymoxanil. The partner Mancozeb acts by its contact action. The mancozeb is fungitoxic when exposed to air, it converts to an isothiocyanate, which inactivates the Sulphahydral (SH) groups in enzymes of fungi. Sometimes the metals are exchanged between mancozeb and enzymes of fungi, thus causing disturbance in fungal enzyme functioning. Other partner Cymoxanil has contact and locally systemic activity. It inhibits Sporulation in fungi.
  • Special Features

    • Specialty Dual action fungicide i.e. contact and locally systemic, which controls diseases by its protective as well as early curative action. Best for controlling resistant fungal population.
    • Good kick-back action – Controls fungi even after 2 days of infection. Specialty fungicide to control diseases caused by oomycetes fungi. (Downy mildew, late blight, etc.) Rapid uptake and trans-location in plant.
    • Long duration disease control.
    • Due to various actions on spores, viz inhibits spore germination, reduce spore viability and inhibits spore’s production, controls spread of disease.
  • Application

For best management of the disease it is wise to spray at the initiation of the disease symptoms/ at probable time of disease occurrence. Preventive application of Noviguard early in season helps in preventing disease outbreak late in season. It is advisable to follow local agricultural universities recommendations.

·         Dosage

2 kg/Ha or 40 g/20 litres of water

·         Available Packs

40 g, 80 g, 250 g, 500g, 1 kg and 5 kg

Novixa International Limited is a Kenyan company within the Jumbo group of companies serving the agriculture inputs sector with pride.


Along Mombasa Road, Kitengela Junction
+254 707 040 440


Get the latest newsabout Novixa

Invalid or empty email
You have successfully subscribed to the newsletter.
Something went wrong. Your subscription failed.

Follow us